Elsevier

Neuroscience

Volume 380, 1 June 2018, Pages 103-110
Neuroscience

Research Article
Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice

https://doi.org/10.1016/j.neuroscience.2018.04.009Get rights and content

Highlights

  • ApoE genotype does not affect initial odor investigation.

  • ApoE genotype modulates behavioral odor habituation.

  • ApoE genotype produces an ApoE4 > ApoE3 > ApoE2 excitability ranking.

  • Deleterious effects of ApoE4 may be due to induced olfactory hyperexcitability.

  • Protective effects of ApoE2 may be due to induced olfactory hypoexcitability.

Abstract

Apolipoprotein E (ApoE) is an important lipid carrier in both the periphery and the brain. The ApoE ε4 allele (ApoE4) is the single most important genetic risk-factor for Alzheimer’s disease (AD) while the ε2 allele (ApoE2) is associated with a lower risk of AD-related neurodegeneration compared to the most common variant, ε3 (ApoE3). ApoE genotype affects a variety of neural circuits; however, the olfactory system appears to provide early biomarkers of ApoE genotype effects. Here, we directly compared olfactory behavior and olfactory system physiology across all three ApoE genotypes in 6-month- and 12-month-old mice with targeted replacement for the human ApoE2, ApoE3, or ApoE4 genes. Odor investigation and habituation were assessed, along with, olfactory bulb and piriform cortical local field potential activity. The results demonstrate that while initial odor investigation was unaffected by ApoE genotype, odor habituation was impaired in E4 relative to E2 mice, with E3 mice intermediate in function. There was also significant deterioration of odor habituation from 6 to 12 months of age regardless of the ApoE genotype. Olfactory system excitability and odor responsiveness were similarly determined by ApoE genotype, with an ApoE4 > ApoE3 > ApoE2 excitability ranking. Although motivated behavior is influenced by many processes, hyper-excitability of ApoE4 mice may contribute to impaired odor habituation, while hypo-excitability of ApoE2 mice may contribute to its protective effects. Given that these ApoE mice do not have AD pathology, our results demonstrate how ApoE affects the olfactory system at early stages, prior to the development of AD.

Introduction

Apolipoprotein E (ApoE) is the primary carrier of cholesterol within the brain, and ApoE genotype is an important determinant of an individual’s risk for developing Alzheimer’s disease (AD) (Corder et al., 1993, Farrer et al., 1997, Bu, 2009, Liu et al., 2013). Three alleles of ApoE occur in humans: ε2 (cys112, cys158; ∼6% of the ApoE alleles in the population), ε3 (cys112, arg158; the most abundant allele at ∼80%), and ε4 (arg112, arg158; ∼14%) (Mahley, 1988, Mahley and Rall, 2000). ApoE4, in a dose-dependent manner, is the single most important genetic risk-factor for AD (Corder et al., 1993, Farrer et al., 1997, Bu, 2009, Liu et al., 2013). ApoE3 is viewed as the neutral allele in terms of neurodegenerative risk (Corder et al., 1993, Mahley and Rall, 2000, Liu et al., 2013) (and most closely resembles murine ApoE (Raffai et al., 2001)). ApoE2 is associated with a lower risk of AD-related neurodegeneration (Corder et al., 1994, Liu et al., 2013), delayed age of onset of AD, and a greater likelihood of survival to advanced age compared to the ApoE3 and ApoE4 alleles [reviewed in (Suri et al., 2013)]. In addition to AD, there is increasing evidence that ApoE is involved in several other disorders, with ApoE4 often exerting a deleterious and ApoE2 a protective effect; while not all studies have found a difference between ApoE2 and ApoE3 carriers [reviewed in (Suri et al., 2013)], both ApoE4 and ApoE2 appear to be associated with hemorrhagic and ischemic cerebrovascular disease [reviewed in (Liu et al., 2013, Suri et al., 2013, Lopez et al., 2014)], with a high risk of argyrophilic grain disease and frontotemporal dementia [reviewed in (Suri et al., 2013)]. ApoE2 also appears to confer an increased incidence and severity of posttraumatic stress disorder (PTSD) (Freeman et al., 2005, Kim et al., 2013, Johnson et al., 2015). While the effects of ApoE4 have been extensively studied, the inconsistencies among a small number of studies regarding the effect of ApoE2 may in part be due to challenges related to its low frequency allele.

While ApoE genotype may affect a myriad of neural circuits and functions, the olfactory system and olfactory perception appear to be a unique and early biomarker of ApoE genotype. In humans, ApoE4 carriers show early emergence of olfactory dysfunction (Price et al., 1991, Bacon et al., 1998, Mesholam et al., 1998, Murphy et al., 1998, Graves et al., 1999, Gilbert and Murphy, 2004, Josefsson et al., 2017, Peng et al., 2017), show impaired odor identification (Murphy et al., 1998, Olofsson et al., 2010, Olofsson et al., 2016), and modified olfactory related evoked potentials (Kowalewski and Murphy, 2012, Morgan and Murphy, 2012) prior to other forms of cognitive impairment, including AD impairment associated with amyloid β and tau pathology. In mice, ApoE4 impairs short-term odor memory and induces olfactory system hyperexcitability including in the olfactory bulb (OB) and piriform cortex (PCX) (Peng et al., 2017) as well as the lateral entorhinal cortex (Nuriel et al., 2017) The olfactory system is suitable for assessing links between cell biology, circuit function and behavior given its relatively simple circuitry and the availability of reliable, robust behavioral assays in both humans and non-human animals. ApoE is important for neuroregeneration of the rodent olfactory system (Nathan et al., 2005), and ApoE knock-out mice show impaired olfactory detection (Nathan et al., 2004). This olfactory dysfunction is associated with neurophysiological (Mesholam et al., 1998, Corby et al., 2012, Kowalewski and Murphy, 2012, Peng et al., 2017), structural (Tanaka et al., 1998, Hashimoto et al., 2001) and cellular changes (Tsuboi et al., 2003, Nathan et al., 2005, Hussain et al., 2013) in olfactory regions of the brain. Understanding how ApoE isoforms may influence olfactory system function and perception would provide important insights into ApoE4 as a major risk factor for olfactory and cognitive decline.

Here, we directly compared olfactory behavior and olfactory system physiology across all three ApoE genotypes in mice that are homozygous for human ApoE2, ApoE3, or ApoE4. We hypothesized a genotype-dependent gradient in odor habituation and olfactory system excitability, such that, for example, ApoE4 mice would display hyper-excitability and impaired behavioral habituation, and ApoE2 mice hypo-excitability and increased behavioral habituation, relative to ApoE3 mice. The results were in line with our hypotheses and they extend previous work (Peng et al., 2017).

Section snippets

Study approval

All animal procedures were performed in accordance with the Nathan S. Kline Institute (NKI) for Psychiatric Research Institutional Animal Care Committee’s approval.

Mice

Mice used in this experiment were homozygous for human ApoE2, ApoE3, and ApoE4 genes on a C57BL/6 background which are from long-standing colonies at NKI. These targeted-replacement mice express human ApoE under the control of the endogenous murine promoter (Sullivan et al., 1997), which allows for the expression of human ApoE at

Olfactory behavior

Independent of age or genotype, mice readily investigated novel odors presented to their homecage, suggesting no difference in behavioral odor responsiveness. As shown in Fig. 1, there was no age (F(1,34) = 0.001, p = 0.97) or genotype (F(2,34) = 1.3, p = 0.3) difference in the amount of time spent investigating the initial presentation of a novel odor.

In contrast, odor habituation was significantly affected by genotype (Fig. 2). For habituation, the analysis strategy was informed by prior

Discussion

Despite olfaction emerging as a system of importance to study the behavioral and physiological effects of ApoE, research remains limited. The present results demonstrate that while the initial tendency of mice to investigate novel odors is unaffected by ApoE genotype, odor habituation is impaired in E4 relative to E2 mice, with E3 mice presenting an intermediate functional level. Memory impairment in this simple task emerges in E4 mice by 6 months, as previously reported (Peng et al., 2017).

Acknowledgments

We thank Dr. Monika Pawlik for her expert assistance with our mouse colonies. This work was supported by the NIH (P01 AG017617 to EL and PMM, and R01 AG057517 to EL, PMM, and DAW; KP was additionally supported by an NIH postdoctoral research training grant T32-AG052909). JKO was supported by a Pro Futura Scientia VII fellowship and research grants from the Marianne and Marcus Wallenberg Foundation (MMW 2014:0178) and the Swedish Foundation for the Humanities and Social Sciences (M14–0375:1).

References (57)

  • J.L. Price et al.

    The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimers-disease

    Neurobiol Aging

    (1991)
  • I. Reinvang et al.

    APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease

    Neurosci Biobehav Rev

    (2013)
  • P.M. Sullivan et al.

    Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis

    J Biol Chem

    (1997)
  • P.M. Sullivan et al.

    Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice

    Neuroscience

    (2004)
  • B. Sun et al.

    Imbalance between GABAergic and Glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease

    Cell Stem Cell

    (2009)
  • S. Suri et al.

    The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2

    Neurosci Biobehav Rev

    (2013)
  • P.B. Verghese et al.

    Apolipoprotein E in Alzheimer's disease and other neurological disorders

    Lancet Neurol

    (2011)
  • L. Verret et al.

    Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model

    Cell

    (2012)
  • D.A. Wilson et al.

    Cortical processing of odor objects

    Neuron

    (2011)
  • W. Xu et al.

    Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AbetaPP metabolites in the Tg2576 mouse model of Alzheimer's disease

    Exp Neurol

    (2015)
  • K.A. Andrews et al.

    Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials

    PLoS One

    (2013)
  • A.W. Bacon et al.

    Very early changes in olfactory functioning due to Alzheimer's disease and the role of Apolipoprotein E in olfaction

    Ann N Y Acad Sci

    (1998)
  • G. Bu

    Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

    Nat Rev Neurosci

    (2009)
  • E.H. Corder et al.

    Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

    Science

    (1993)
  • E.H. Corder et al.

    Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease

    Nat Genet

    (1994)
  • P.E. Cramer et al.

    ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models

    Science

    (2012)
  • D.P. Devanand et al.

    Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up

    Am J Psychiatry

    (2000)
  • L.A. Farrer et al.

    Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

    JAMA

    (1997)
  • Cited by (0)

    View full text